Cambrex Corp (CBM) 42.07 $CBM
Cambrex Up 43.0% Since SmarTrend Uptrend Call (CBM)
Comtex SmarTrend(R) - Wed Apr 22, 9:17AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 3 months, Cambrex has returned 43.03% as of today's recent price of $42.53.
CBM: 42.07 (-0.65)
New Innovator IBD 50 ETF Makes Strong Debut - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Apr 22, 9:00AM CDT
Have a look to the new ETF from Innovator that has easily crushed its peers in garnering investors attention in the initial days.
CNC: 70.90 (+0.12), CBM: 42.07 (-0.65), IWO: 154.17 (+0.16), PDP: 43.78 (+0.04), FV: 24.38 (+0.02), VBK: 135.34 (+0.13), PAYC: 32.95 (-0.16), FFTY: 25.30 (unch)
My Top Life Sciences Tools And Services Stocks For 2015
Stan Stafford - at Seeking Alpha - Wed Apr 22, 12:57AM CDT
PRXL: 67.12 (-0.42), Q: 66.45 (-0.25), CBM: 42.07 (-0.65), TMO: 130.69 (-3.75), NEO: 4.84 (-0.03), ILMN: 190.04 (-9.27), LMNX: 16.34 (-0.01), CRL: 78.06 (-0.53), PKI: 51.69 (-0.02), ICLR: 69.24 (+1.28), MTD: 324.14 (+0.66)
Looking For Action? S&P 1500 Most Volatile Stocks
Bespoke Investment Group - at Seeking Alpha - Tue Apr 21, 3:30AM CDT
For traders with a short-term time horizon who are looking for big moves over a short period, we have updated our list of the 50 S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread...
CRR: 33.68 (-0.12), NBR: 15.05 (+0.68), BCEI: 24.50 (-0.20), LL: 33.86 (+0.50), PTEN: 21.01 (+0.68), MNTA: 18.62 (+0.56), HOS: 20.11 (-0.89), KOP: 22.68 (+0.05), DO: 30.07 (-0.02), BBG: 9.80 (-0.41), SGY: 16.54 (-0.83), FTK: 15.56 (+0.10), SPN: 23.84 (+0.41), ROVI: 19.46 (+0.10), WPX: 13.40 (+0.16), AKRX: 53.70 (-1.69), MCF: 20.44 (-0.02), ZEUS: 10.79 (-0.32), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), CCRN: 11.10 (+0.01), ESV: 24.03 (+0.13), ANIP: 69.79 (+1.24), SGNT: 25.43 (-0.29), PDCE: 55.02 (-0.03), NE: 16.18 (+0.14), UIHC: 20.78 (+0.18), TNGO: 14.04 (-0.16), SGMS: 12.48 (+0.25), GIFI: 15.33 (+0.25), TDW: 24.66 (-0.59), CENX: 13.28 (+0.17), UNT: 30.38 (+0.43), RIG: 16.85 (-0.18), SPOK: 20.73 (+0.23), GPRE: 30.59 (-0.02), SYRG: 12.37 (+0.06), GEOS: 20.76 (+0.57), CBM: 42.07 (-0.65), SM: 55.21 (+1.23), TESO: 12.48 (+0.09), ROSE: 22.02 (-0.50), RGEN: 33.37 (+0.51), VDSI: 25.11 (-0.58), SKYW: 14.22 (unch), GLF: 13.77 (-0.11), SLCA: 36.94 (+0.70), RDC: 19.42 (-0.13), EHTH: 11.44 (+0.07)
Cambrex Shares Up 43.8% Since SmarTrend's Buy Recommendation (CBM)
Comtex SmarTrend(R) - Tue Apr 14, 4:47PM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 2 months, Cambrex has returned 43.77% as of today's recent price of $42.75.
CBM: 42.07 (-0.65)
AVEO Upgraded to Strong Buy, Add to Your Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 3:02PM CDT
On Apr 14, Zacks Investment Research upgraded AVEO Pharmaceuticals, Inc. (AVEO) to a Zacks Rank #1 (Strong Buy); is it in your portfolio?
CBM: 42.07 (-0.65), OPHT: 52.35 (+1.09), AVEO: 2.04 (+0.12), AMGN: 169.10 (+0.64)
Amgen Upgraded to Strong Buy, Perfect for Your Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 2:27PM CDT
On Apr 11, Zacks Investment Research upgraded Amgen Inc. (AMGN) to a Zacks Rank #1 (Strong Buy); is it in your portfolio?
CYTK: 7.29 (-0.09), CBM: 42.07 (-0.65), KITE: 57.56 (-1.43), AMGN: 169.10 (+0.64)
5 IBD 50s Offer Triple-Digit Earnings Growth Views
at Investor's Business Daily - Sat Apr 11, 7:02AM CDT
As earnings seasons kicks into gear, here are the top five IBD 50 stocks expected to bring in the biggest year-over-year profit gains. The IBD 50 rounds up the best and brightest stocks that boast top fundamentals and strong relative price strength....
AMBA: 74.57 (+0.18), GPRO: 46.25 (+1.94), ACT: 295.22 (+0.69), QRVO: 74.48 (+0.41), SWKS: 96.83 (+1.41), CBM: 42.07 (-0.65), AKRX: 53.70 (-1.69), AAPL: 128.62 (+1.71), BITA: 57.15 (+0.89), ATHM: 52.09 (+0.08), AVGO: 127.89 (+4.79)
Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 3:49PM CDT
Exelixis' (EXEL) lead drug Cometriq gets fast-track status in the U.S. for the treatment of kidney cancer.
CBM: 42.07 (-0.65), CLDX: 28.95 (+1.08), EXEL: 3.12 (+0.05)
Oncolytics' Reolysin Filed for Gastric Cancer Orphan Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 4:10PM CDT
Oncolytics (ONCY) submitted an application to the FDA seeking orphan drug status for Reolysin for the treatment of gastric cancer.
CYTK: 7.29 (-0.09), ONCY: 0.80 (unch), CBM: 42.07 (-0.65), AMGN: 169.10 (+0.64)
Halozyme to Advance PEGPH20 Following FDA Meet - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 3:20PM CDT
Halozyme (HALO) announced that it will advance PEGPH20 into a phase III study following its meeting with the FDA.
CYTK: 7.29 (-0.09), HALO: 16.03 (+0.15), CBM: 42.07 (-0.65), AMGN: 169.10 (+0.64)
Celldex Initiates Study on Varlilumab for Metastatic Melanoma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 4:14PM CDT
Celldex (CLDX) initiates a phase I/II study to evaluate varlilumab in combination with Bristol-Myers' (BMY) Yervoy and CDX-1401.
CBM: 42.07 (-0.65), CLDX: 28.95 (+1.08), BMY: 66.60 (-0.21)
Shares of CBM Up 36.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 07, 11:24AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 2 months, Cambrex has returned 36.86% as of today's recent price of $40.70.
CBM: 42.07 (-0.65)
Cambrex To Present At The 14th Annual Needham Healthcare Conference
PR Newswire - Tue Apr 07, 10:36AM CDT
Cambrex Corporation (NYSE: CBM, "Cambrex"
is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on April 14, 2015 at 4:20 p.m. EDT in New York City.
CBM: 42.07 (-0.65)
Stocks Claw Out Slender Gains; Tesla, Mattel, Cambrex Advance
at Investor's Business Daily - Mon Apr 06, 9:35AM CDT
Stocks bounced out of the three-day holiday weekend, reversing early losses into thin gains on rising oil prices and mixed economic data. The Dow Jones industrial average and the Nasdaq added 0.1% each. The S&P 500 ticked up 0.2% as a cross-section...
KO: 41.31 (+0.53), TSLA: 219.44 (+10.03), JNJ: 100.43 (+0.13), CBM: 42.07 (-0.65), MTSI: 34.46 (-0.27), JPM: 62.94 (+0.63), MAT: 28.36 (+1.14), MCD: 97.84 (+2.97), ALK: 64.31 (-0.62), IPGP: 97.60 (+1.46)
The Medicines Co. Settles Angiomax Patent Dispute with Sun - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 3:58PM CDT
The Medicines Company (MDCO) settles Angiomax patent dispute with Sun Pharma.
LCI: 66.45 (-0.28), CBM: 42.07 (-0.65), MDCO: 27.84 (+0.25), HSP: 87.80 (+0.04)
Stock Indexes Post Gains, But Volume Is Light
at Investor's Business Daily - Thu Apr 02, 12:34PM CDT
Stocks posted small gains in light volume Thursday as the market headed toward the three-day weekend. The Nasdaq was up 0.2% while the S&P 500 and the Dow Jones industrial average added 0.4% and 0.3% respectively. Volume in the stock market today was...
DHI: 27.03 (-1.53), LEN: 48.41 (-0.73), HD: 112.99 (-0.18), CBM: 42.07 (-0.65)
Stocks Mildly Higher, And CarMax Hits Accelerator
at Investor's Business Daily - Thu Apr 02, 11:01AM CDT
Stocks were trading moderately higher in preholiday trading, holding on to early gains. Volume was tracking lighter. The Nasdaq was up 0.2% while the S&P 500 and the Dow Jones industrial average gained 0.4% in the stock market today. Even though...
KMX: 70.84 (-0.04), KRNT: 14.99 (unch), CBM: 42.07 (-0.65), MCD: 97.84 (+2.97), GOOGL: 549.18 (+6.26)
Stocks Rise As Dollar, Oil Slip; Lorillard And Reynolds Surge
at Investor's Business Daily - Thu Apr 02, 9:40AM CDT
Stocks improved from mixed trade into moderate gains early Thursday, as investors looked to wrap up a short holiday week. The Dow Jones industrial average chiseled out a 0.6% gain. The S&P 500 jumped 0.5% and the Nasdaq climbed 0.4%. Volume was...
RAI: 76.04 (+0.43), KMX: 70.84 (-0.04), CBM: 42.07 (-0.65), ABG: 86.97 (-0.16), EXPE: 99.47 (+1.16), LO: 70.77 (-0.23), THRM: 52.19 (+0.03)
Cambrex Up 43.0% Since SmarTrend Uptrend Call (CBM)
Comtex SmarTrend(R) - Wed Apr 22, 9:17AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 3 months, Cambrex has returned 43.03% as of today's recent price of $42.53.
CBM: 42.07 (-0.65)
New Innovator IBD 50 ETF Makes Strong Debut - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Apr 22, 9:00AM CDT
Have a look to the new ETF from Innovator that has easily crushed its peers in garnering investors attention in the initial days.
CNC: 70.90 (+0.12), CBM: 42.07 (-0.65), IWO: 154.17 (+0.16), PDP: 43.78 (+0.04), FV: 24.38 (+0.02), VBK: 135.34 (+0.13), PAYC: 32.95 (-0.16), FFTY: 25.30 (unch)
My Top Life Sciences Tools And Services Stocks For 2015
Stan Stafford - at Seeking Alpha - Wed Apr 22, 12:57AM CDT
PRXL: 67.12 (-0.42), Q: 66.45 (-0.25), CBM: 42.07 (-0.65), TMO: 130.69 (-3.75), NEO: 4.84 (-0.03), ILMN: 190.04 (-9.27), LMNX: 16.34 (-0.01), CRL: 78.06 (-0.53), PKI: 51.69 (-0.02), ICLR: 69.24 (+1.28), MTD: 324.14 (+0.66)
Looking For Action? S&P 1500 Most Volatile Stocks
Bespoke Investment Group - at Seeking Alpha - Tue Apr 21, 3:30AM CDT
For traders with a short-term time horizon who are looking for big moves over a short period, we have updated our list of the 50 S&P 1500 stocks trading above $10 that have the largest intraday high-low ranges (based on the average percent spread...
CRR: 33.68 (-0.12), NBR: 15.05 (+0.68), BCEI: 24.50 (-0.20), LL: 33.86 (+0.50), PTEN: 21.01 (+0.68), MNTA: 18.62 (+0.56), HOS: 20.11 (-0.89), KOP: 22.68 (+0.05), DO: 30.07 (-0.02), BBG: 9.80 (-0.41), SGY: 16.54 (-0.83), FTK: 15.56 (+0.10), SPN: 23.84 (+0.41), ROVI: 19.46 (+0.10), WPX: 13.40 (+0.16), AKRX: 53.70 (-1.69), MCF: 20.44 (-0.02), ZEUS: 10.79 (-0.32), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), CCRN: 11.10 (+0.01), ESV: 24.03 (+0.13), ANIP: 69.79 (+1.24), SGNT: 25.43 (-0.29), PDCE: 55.02 (-0.03), NE: 16.18 (+0.14), UIHC: 20.78 (+0.18), TNGO: 14.04 (-0.16), SGMS: 12.48 (+0.25), GIFI: 15.33 (+0.25), TDW: 24.66 (-0.59), CENX: 13.28 (+0.17), UNT: 30.38 (+0.43), RIG: 16.85 (-0.18), SPOK: 20.73 (+0.23), GPRE: 30.59 (-0.02), SYRG: 12.37 (+0.06), GEOS: 20.76 (+0.57), CBM: 42.07 (-0.65), SM: 55.21 (+1.23), TESO: 12.48 (+0.09), ROSE: 22.02 (-0.50), RGEN: 33.37 (+0.51), VDSI: 25.11 (-0.58), SKYW: 14.22 (unch), GLF: 13.77 (-0.11), SLCA: 36.94 (+0.70), RDC: 19.42 (-0.13), EHTH: 11.44 (+0.07)
Cambrex Shares Up 43.8% Since SmarTrend's Buy Recommendation (CBM)
Comtex SmarTrend(R) - Tue Apr 14, 4:47PM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 2 months, Cambrex has returned 43.77% as of today's recent price of $42.75.
CBM: 42.07 (-0.65)
AVEO Upgraded to Strong Buy, Add to Your Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 3:02PM CDT
On Apr 14, Zacks Investment Research upgraded AVEO Pharmaceuticals, Inc. (AVEO) to a Zacks Rank #1 (Strong Buy); is it in your portfolio?
CBM: 42.07 (-0.65), OPHT: 52.35 (+1.09), AVEO: 2.04 (+0.12), AMGN: 169.10 (+0.64)
Amgen Upgraded to Strong Buy, Perfect for Your Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 2:27PM CDT
On Apr 11, Zacks Investment Research upgraded Amgen Inc. (AMGN) to a Zacks Rank #1 (Strong Buy); is it in your portfolio?
CYTK: 7.29 (-0.09), CBM: 42.07 (-0.65), KITE: 57.56 (-1.43), AMGN: 169.10 (+0.64)
5 IBD 50s Offer Triple-Digit Earnings Growth Views
at Investor's Business Daily - Sat Apr 11, 7:02AM CDT
As earnings seasons kicks into gear, here are the top five IBD 50 stocks expected to bring in the biggest year-over-year profit gains. The IBD 50 rounds up the best and brightest stocks that boast top fundamentals and strong relative price strength....
AMBA: 74.57 (+0.18), GPRO: 46.25 (+1.94), ACT: 295.22 (+0.69), QRVO: 74.48 (+0.41), SWKS: 96.83 (+1.41), CBM: 42.07 (-0.65), AKRX: 53.70 (-1.69), AAPL: 128.62 (+1.71), BITA: 57.15 (+0.89), ATHM: 52.09 (+0.08), AVGO: 127.89 (+4.79)
Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 3:49PM CDT
Exelixis' (EXEL) lead drug Cometriq gets fast-track status in the U.S. for the treatment of kidney cancer.
CBM: 42.07 (-0.65), CLDX: 28.95 (+1.08), EXEL: 3.12 (+0.05)
Oncolytics' Reolysin Filed for Gastric Cancer Orphan Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 4:10PM CDT
Oncolytics (ONCY) submitted an application to the FDA seeking orphan drug status for Reolysin for the treatment of gastric cancer.
CYTK: 7.29 (-0.09), ONCY: 0.80 (unch), CBM: 42.07 (-0.65), AMGN: 169.10 (+0.64)
Halozyme to Advance PEGPH20 Following FDA Meet - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 3:20PM CDT
Halozyme (HALO) announced that it will advance PEGPH20 into a phase III study following its meeting with the FDA.
CYTK: 7.29 (-0.09), HALO: 16.03 (+0.15), CBM: 42.07 (-0.65), AMGN: 169.10 (+0.64)
Celldex Initiates Study on Varlilumab for Metastatic Melanoma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 4:14PM CDT
Celldex (CLDX) initiates a phase I/II study to evaluate varlilumab in combination with Bristol-Myers' (BMY) Yervoy and CDX-1401.
CBM: 42.07 (-0.65), CLDX: 28.95 (+1.08), BMY: 66.60 (-0.21)
Shares of CBM Up 36.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 07, 11:24AM CDT
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on February 6th, 2015 at $29.74. In approximately 2 months, Cambrex has returned 36.86% as of today's recent price of $40.70.
CBM: 42.07 (-0.65)
Cambrex To Present At The 14th Annual Needham Healthcare Conference
PR Newswire - Tue Apr 07, 10:36AM CDT
Cambrex Corporation (NYSE: CBM, "Cambrex"
is pleased to announce that Steven Klosk, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on April 14, 2015 at 4:20 p.m. EDT in New York City. CBM: 42.07 (-0.65)
Stocks Claw Out Slender Gains; Tesla, Mattel, Cambrex Advance
at Investor's Business Daily - Mon Apr 06, 9:35AM CDT
Stocks bounced out of the three-day holiday weekend, reversing early losses into thin gains on rising oil prices and mixed economic data. The Dow Jones industrial average and the Nasdaq added 0.1% each. The S&P 500 ticked up 0.2% as a cross-section...
KO: 41.31 (+0.53), TSLA: 219.44 (+10.03), JNJ: 100.43 (+0.13), CBM: 42.07 (-0.65), MTSI: 34.46 (-0.27), JPM: 62.94 (+0.63), MAT: 28.36 (+1.14), MCD: 97.84 (+2.97), ALK: 64.31 (-0.62), IPGP: 97.60 (+1.46)
The Medicines Co. Settles Angiomax Patent Dispute with Sun - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 02, 3:58PM CDT
The Medicines Company (MDCO) settles Angiomax patent dispute with Sun Pharma.
LCI: 66.45 (-0.28), CBM: 42.07 (-0.65), MDCO: 27.84 (+0.25), HSP: 87.80 (+0.04)
Stock Indexes Post Gains, But Volume Is Light
at Investor's Business Daily - Thu Apr 02, 12:34PM CDT
Stocks posted small gains in light volume Thursday as the market headed toward the three-day weekend. The Nasdaq was up 0.2% while the S&P 500 and the Dow Jones industrial average added 0.4% and 0.3% respectively. Volume in the stock market today was...
DHI: 27.03 (-1.53), LEN: 48.41 (-0.73), HD: 112.99 (-0.18), CBM: 42.07 (-0.65)
Stocks Mildly Higher, And CarMax Hits Accelerator
at Investor's Business Daily - Thu Apr 02, 11:01AM CDT
Stocks were trading moderately higher in preholiday trading, holding on to early gains. Volume was tracking lighter. The Nasdaq was up 0.2% while the S&P 500 and the Dow Jones industrial average gained 0.4% in the stock market today. Even though...
KMX: 70.84 (-0.04), KRNT: 14.99 (unch), CBM: 42.07 (-0.65), MCD: 97.84 (+2.97), GOOGL: 549.18 (+6.26)
Stocks Rise As Dollar, Oil Slip; Lorillard And Reynolds Surge
at Investor's Business Daily - Thu Apr 02, 9:40AM CDT
Stocks improved from mixed trade into moderate gains early Thursday, as investors looked to wrap up a short holiday week. The Dow Jones industrial average chiseled out a 0.6% gain. The S&P 500 jumped 0.5% and the Nasdaq climbed 0.4%. Volume was...
RAI: 76.04 (+0.43), KMX: 70.84 (-0.04), CBM: 42.07 (-0.65), ABG: 86.97 (-0.16), EXPE: 99.47 (+1.16), LO: 70.77 (-0.23), THRM: 52.19 (+0.03)
